Previous close | 0.00 |
Open | 45.73 |
Bid | 55.89 x 40000 |
Ask | 60.64 x 39400 |
Day's range | 45.73 - 45.73 |
52-week range | 35.91 - 45.73 |
Volume | |
Avg. volume | 229 |
Market cap | 29.902B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 24.99 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.80 (2.02%) |
Ex-dividend date | 27 Dec 2024 |
1y target est | N/A |
PALO ALTO, Calif., November 10, 2023--Recor Medical, Inc. announces the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation system for the treatment of hypertension.
PALO ALTO, Calif., November 08, 2023--Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
PALO ALTO, Calif., October 26, 2023--Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd., announced positive results in a late-breaking session at TCT 2023.